Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs. Delayed Everolimus in Heart Transplant
NCT01017029Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in heart transplantation, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
everolimus
03
Conditions
heart transplantation
Beyond the preview
Go deeper on NCT01017029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017029.